{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T03:54:53Z","timestamp":1769831693845,"version":"3.49.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1016\/j.clindermatol.2003.11.001","type":"journal-article","created":{"date-parts":[[2004,5,29]],"date-time":"2004-05-29T17:36:16Z","timestamp":1085852176000},"page":"60-65","source":"Crossref","is-referenced-by-count":20,"title":["Botulinum toxin-B and the management of hyperhidrosis"],"prefix":"10.1016","volume":"22","author":[{"given":"Leslie S","family":"Baumann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica L","family":"Halem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2003.11.001_BIB1","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3928\/0191-3913-19800101-06","article-title":"Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery","volume":"17","author":"Scott","year":"1980","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"10.1016\/j.clindermatol.2003.11.001_BIB2","unstructured":"American Society for Aesthetic Plastic Surgery. 2000 Statistics on Cosmetic Surgery. New York: American Society for Aesthetic Plastic Surgery, 2001"},{"key":"10.1016\/j.clindermatol.2003.11.001_BIB3","doi-asserted-by":"crossref","unstructured":"Blitzer A, Binder WJ, Aviv JE, et al. The management of hyperfunctional facial lines with botulinum toxin. A collaborative study of 210 injection sites in 162 patients. Arch Otolaryngol Head Neck Surg 1997;123:389\u2013392","DOI":"10.1001\/archoto.123.4.389"},{"key":"10.1016\/j.clindermatol.2003.11.001_BIB4","doi-asserted-by":"crossref","unstructured":"Carruthers JD, Carruthers JA. Treatment of glabellar frown lines with C. botulinum A exotoxin. J Dermatol Surg Oncol 1992;18:17\u201321","DOI":"10.1111\/j.1524-4725.1992.tb03295.x"},{"key":"10.1016\/j.clindermatol.2003.11.001_BIB5","doi-asserted-by":"crossref","unstructured":"Carruthers A, Carruthers J. History of the cosmetic use of botulinum A exotoxin. Dermatol Surg 1998;24:1168\u20131170","DOI":"10.1111\/j.1524-4725.1998.tb04092.x"},{"key":"10.1016\/j.clindermatol.2003.11.001_BIB6","first-page":"75","article-title":"The treatment of focal hyperhidrosis with botulinum toxin","volume":"4","author":"Naver","year":"1997","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.clindermatol.2003.11.001_BIB7","doi-asserted-by":"crossref","unstructured":"Naumann M. Evidence-based medicine: botulinum toxin in focal hyperhidrosis. J Neurol 2001;(Supp 1):31\u201333","DOI":"10.1007\/PL00007817"},{"key":"10.1016\/j.clindermatol.2003.11.001_BIB8","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0190-9622(99)70258-6","article-title":"Side-controlled intradermal injection of botulinum toxin type A in recalcitrant axillary hyperhidrosis","volume":"41","author":"Heckmann","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2003.11.001_BIB9","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJM200102153440704","article-title":"Botulinum toxin type A for axillary hyperhidrosis (excessive sweating)","volume":"344","author":"Heckmann","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2003.11.001_BIB10","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s002660010046","article-title":"Treatment of axillary and palmar hyperhidrosis with botulinum toxin","volume":"24","author":"Goldman","year":"2000","journal-title":"Aesthetic Plast Surg"},{"key":"10.1016\/j.clindermatol.2003.11.001_BIB11","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/PL00007817","article-title":"Evidence-based medicine","volume":"248","author":"Naumann","year":"2001","journal-title":"J Neurol"},{"key":"10.1016\/j.clindermatol.2003.11.001_BIB12","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/S0190-9622(98)70297-X","article-title":"Botulinum toxin in the treatment of palmar hyperhidrosis","volume":"39","author":"Holmes","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2003.11.001_BIB13","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1046\/j.1468-1331.2000.00014.x","article-title":"Palmar and axillary hyperhidrosis treated with botulinum toxin","volume":"7","author":"Naver","year":"2000","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.clindermatol.2003.11.001_BIB14","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1136\/bmj.323.7313.596","article-title":"Multicenter European axillary botulinum toxin type A study","volume":"323","author":"Naumann","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.clindermatol.2003.11.001_BIB15","unstructured":"Naumann M, Lowe N. A randomized controlled parallel study evaluating botulinum toxin type A in the treatment of axillary hyperhidrosis. J Eur Acad Dermatol Venereol 2000;14:53\u201355"},{"key":"10.1016\/j.clindermatol.2003.11.001_BIB16","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.1365-2133.1997.tb02139.x","article-title":"Double blind trial of botulinum toxin for the treatment of focal hyperhidrosis of the palms","volume":"136","author":"Schnider","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2003.11.001_BIB17","doi-asserted-by":"crossref","unstructured":"Lowe NJ, Yamauchi PS, Lask GP, et al. Efficacy and safety of botulinum toxin type A in the treatment of palmar hyperhidrosis: A double-blinded randomized placebo-controlled study. Dermatol Surg 2002;28:822\u2013827","DOI":"10.1097\/00042728-200209000-00008"},{"key":"10.1016\/j.clindermatol.2003.11.001_BIB18","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0003-9993(98)90020-X","article-title":"Axillary hyperhidrosis","volume":"79","author":"Odderson","year":"1998","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.clindermatol.2003.11.001_BIB19","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S1076-0512(98)00077-6","article-title":"Botulinum toxin type A for axillary hyperhidrosis","volume":"24","author":"Glogau","year":"1998","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2003.11.001_BIB20","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1001\/archderm.134.3.301","article-title":"Focal hyperhidrosis. Effective treatment with intracutaneous botulinum toxin","volume":"134","author":"Naumann","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2003.11.001_BIB21","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1067\/mjd.2002.118341","article-title":"High\u2013Dose botulinum toxin type A therapy for axillary hyperhidrosis markedly prolongs the relapse-free interval","volume":"46","author":"Wollina","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2003.11.001_BIB22","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/mds.870090216","article-title":"Development of resistance to botulinum toxin type A in patients with torticollis","volume":"9","author":"Greene","year":"1994","journal-title":"Mov Disord"},{"key":"10.1016\/j.clindermatol.2003.11.001_BIB23","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1212\/WNL.43.9.1715","article-title":"Botulinum antibodies in dystonic patients treated with type A botulinum toxin","volume":"43","author":"Zuber","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.clindermatol.2003.11.001_BIB24","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1067\/mjd.2000.105567","article-title":"Pharmacology of botulinum toxin","volume":"43","author":"Huang","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2003.11.001_BIB25","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/14764170260030126","article-title":"Botulinum B treatment of the glabellar and frontalis regions","volume":"4","author":"Spencer","year":"2002","journal-title":"J Cosmet Laser Ther"},{"key":"10.1016\/j.clindermatol.2003.11.001_BIB26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/14764170260030117","article-title":"Botulinum toxins types A and B for brow furrows","volume":"4","author":"Lowe","year":"2002","journal-title":"J Cosmet Laser Ther"},{"key":"10.1016\/j.clindermatol.2003.11.001_BIB27","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1067\/mhn.2002.124706","article-title":"Botulinum toxin type B in the management of hyperkinetic facial lines","volume":"126","author":"Ramirez","year":"2002","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.clindermatol.2003.11.001_BIB28","doi-asserted-by":"crossref","unstructured":"Schwetz BA. First drug for cervical dystonia. JAMA 2001;285:724","DOI":"10.1001\/jama.285.6.724-JFD10001-2-1"},{"key":"10.1016\/j.clindermatol.2003.11.001_BIB29","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1212\/WNL.53.7.1431","article-title":"Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia","volume":"53","author":"Brin","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.clindermatol.2003.11.001_BIB30","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1212\/WNL.53.7.1439","article-title":"Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia","volume":"53","author":"Brashear","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.clindermatol.2003.11.001_BIB31","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1212\/WNL.49.3.701","article-title":"Botulinum toxin type B","volume":"49","author":"Lew","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.clindermatol.2003.11.001_BIB32","series-title":"Cosmetic dermatology","first-page":"139","article-title":"The cosmetic uses of botulinum toxin","author":"Baumann","year":"2002"},{"key":"10.1016\/j.clindermatol.2003.11.001_BIB33","unstructured":"Botulinum toxin advancement. Dermatol Times 2001, July 1"},{"key":"10.1016\/j.clindermatol.2003.11.001_BIB34","unstructured":"Baumann L, et al. A double\u2013blinded, randomized, placebo-controlled pilot study of the safety and efficacy of botulinum toxin type B for the treatment of axillary hyperhidrosis (unpublished data)"},{"key":"10.1016\/j.clindermatol.2003.11.001_BIB35","doi-asserted-by":"crossref","unstructured":"Dressler D, Adib Saberi F, Benecke R. Botilinum toxin type B for treatment of axillar hyperhidrosis. J Neurol 2002;249:1729\u20131732","DOI":"10.1007\/s00415-002-0929-4"},{"key":"10.1016\/j.clindermatol.2003.11.001_BIB36","doi-asserted-by":"crossref","unstructured":"Baumann L. A double-blinded, randomized, placebo-controlled pilot study of the safety and efficacy of botulinum toxin type B for the treatment of palmar hyperhidrosis. Arch Dermatol 2003","DOI":"10.1046\/j.1524-4725.2003.29132.x"},{"key":"10.1016\/j.clindermatol.2003.11.001_BIB37","unstructured":"Myobloc\u2122 package insert. Dublin, Ireland: Elan Pharmaceuticals"},{"key":"10.1016\/j.clindermatol.2003.11.001_BIB38","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1212\/WNL.59.9.1445","article-title":"Ptosis as a remote effect of therapeutic botulinum toxin type B injection","volume":"59","author":"Racette","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.clindermatol.2003.11.001_BIB39","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1001\/archderm.139.2.226","article-title":"Systemic adverse effects after botulinum toxin type B (Myobloc) injections for the treatment of palmar hyperhidrosis","volume":"139","author":"Baumann","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2003.11.001_BIB40","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1159\/000067023","article-title":"Autonomic side effects of botulinum toxin type B treatment of cervical dystonia and hyperhidrosis","volume":"49","author":"Dressler","year":"2003","journal-title":"Eur Neurol"},{"key":"10.1016\/j.clindermatol.2003.11.001_BIB41","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1046\/j.1524-4725.2003.29017.x","article-title":"Comparison of botulinum toxin types A and B","volume":"29","author":"Matarasso","year":"2003","journal-title":"Dermatol Surg"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X03001032?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X03001032?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T09:09:50Z","timestamp":1585818590000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X03001032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["S0738081X03001032"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2003.11.001","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,1]]}}}